BioSense is among the first 31 companies who were handpicked by Johnson & Johnson Innovation to become residents of JLABS@Shanghai, the largest JLABS in its global network. JLABS@Shanghai opened its door to support scientific entrepreneurs in China and Asia and held its Grand Opening on June 27, 2019 in Shanghai at the Shanghai Tower. BioSense CEO, Andy Li, gave a company presentation to introduce BioSense Suzhou Ltd. at the Grand Opening.
Read more about JABS@Shanghai here.
Read more about the Grand Opening in Chinese language here.